Ginkgo Bioworks Holdings (DNA) — Technical state
As of 2026-09-17 — re-computed nightly across the coverage universe. Closelook diary readings, not advice.
Trades +2.5% vs the 50-day and -5% vs the 200-day average, 55.4% below the 52-week high and +46% off the 52-week low; a death cross printed 13 sessions ago. Computed from daily closes.
The moving-average stack
- vs 20-day+11.2%
- vs 50-day+2.5%
- vs 200-day-5%
- 52-week band55.4% off the high · +46% off the low
- Streak2 consecutive up sessions
- CrossoverDeath cross 13 sessions ago
- 50-day crossprice crossed up through the 50-day today
- Stochastic%K 81.5 · %D 51
Continue: the DNA chart & overview · the signal board
FAQ · from the current data · as of 2026-09-17
Quick answers
What is the current Closelook signal on DNA?
Recovery attempt under the 200-day — Trades +2.5% vs the 50-day and -5% vs the 200-day average, 55.4% below the 52-week high and +46% off the 52-week low; a death cross printed 13 sessions ago. Computed from daily closes. As of 2026-09-17; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is DNA above its 50-day and 200-day moving averages?
As of 2026-09-17, Ginkgo Bioworks Holdings trades +2.5% above its 50-day and -5% below its 200-day average, with the 20-day +11.2% away.
How far is DNA from its 52-week high?
55.4% below the 52-week high and 46% above the 52-week low, as of 2026-09-17.
Mentioned on Closelook
Where DNA appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Long reads
- Value Investing — Tech-Free, a Flag of Inconvenience
A portfolio of high-quality slow-growers, dutifully rebalanced, is a portfolio with built-in underperformance DNA .